Regional differences in 5-HT receptors in cerebral and testicular arterioles of the rat as revealed by Ca2+ imaging of real-time confocal microscopy: Variances by artery size and organ specificity

Archives of Histology and Cytology

Volumn 71, Issue 5, 2008, Pages 291-302

  Masu, Kazuki ^a,b   Saino, Tomoyuki ^a   Kuroda, Takashi ^a   Matsuura, Makoto ^a   Russa, Afadhali Denis ^a,c   Ishikita, Naoyuki ^a   Satoh, Yoh Ichi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Medical University   (Tanzania)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; SEROTONIN RECEPTOR;

ANTIBODY SPECIFICITY; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD VESSEL; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; MALE; NONHUMAN; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIOLES; BRAIN; CALCIUM; CALCIUM SIGNALING; MALE; MICROSCOPY, CONFOCAL; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; TESTIS; TIME FACTORS;

EID: 67650106460     PISSN: 09149465     EISSN: 13491717     Source Type: Journal    
DOI: 10.1679/aohc.71.291     Document Type: Article

References (47)

1. Baumgarten HG, Grozdanovic Z: Anatomy of the central serotoninergic projection systems. In: Serotoninergic neurons and 5-HT receptors in the CNS (Baumgarten HG, Gothert M, ed) Springer-Verlag, Berlin, 1997 (p.41-89).
2. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529 (2003). (Pubitemid 36773404)
3. Bolton TB, Gordienko DV: Confocal imaging of calcium release events in single smooth muscle cells. Acta Physiol Scand 164: 567-575 (1998). (Pubitemid 29015675)
4. 2+ signals. J Cell Sci 114: 2213-2222 (2001).
5. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR: Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563-576 (1986). (Pubitemid 16056520)
6. Cohen RA, Shepherd JT, Vanhoutte PM: 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 245: H1077-H1080 (1983). (Pubitemid 14212766)
7. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ: Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs 5: 55-60 (2004).
8. Ebashi S: Excitation-contraction coupling. Annu Rev Physiol 38: 293-313 (1976).
9. Faraci FM, Heistad DD: Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66: 8-17 (1990). (Pubitemid 20033921)
10. Faraci FM, Heistad DD: Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53-97 (1998). (Pubitemid 28070975)
11. Fozard JR: The pharmacological basis of migrane treatment. In: Migrane: Clinical & research aspects (Blau J, ed). The Johns Hopkins University Press, Baltimore, 1987 (p.165-184).
12. Fozard JR: 5-HT in migrane: evidence from 5-HT receptor antagonists for a neuronal aetiology . In: Migrane: A spectrum of ideas (Sandler M, Collins G, ed), Oxford University Press, Oxford, 1989 (p.128-141).
13. Gerhardt CC, van Heerikhuizen H: Functional characteristics of heterologously expressed 5-HT receptors. Eur J Pharmacol 334: 1-23 (1997). (Pubitemid 27417803)
14. Hamel E, Robert JP, Young AR, MacKenzie ET: Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. J Pharmacol Exp Ther 249: 879-889 (1989). (Pubitemid 19166672)
15. Harper AM, MacKenzie ET: Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats. J Physiol 271: 735-746 (1977). (Pubitemid 8182517)
16. Hartig PR, Hoyer D, Humphrey PP, Martin GR: Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Parmacol Sci 17: 103-105 (1996) (Pubitemid 126684695)
17. Hossmann KA: Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 8: 95-101 (1997).
18. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46 : 157-203 (1994). (Pubitemid 24185150)
19. Hoyer D, Hannon JP, Martin GR: Molecular, pharma cological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554 (2002). (Pubitemid 34219205)
20. 2+ concentration in single vascular smooth muscle cells in situ. EMBO J 13 : 5026-5031 (1994).
21. 2+ sparks in intact cerebral arteries. Am J Physiol 274 : C1755-C1761 (1998).
22. Li Z, Zhang Q, Zhao S, Wei M, Shenghui Z, Cong H, Ouda H, Odajima K, Takemura H: Responsiveness of cytosolic free calcium concentration in cultured rat pulmonary arterial smooth muscle cells: confocal microscopic measurement. Res Commun Mol Pathol Pharmacol 97 : 47-52 (1997). (Pubitemid 27362628)
23. MacKenzie ET, Scatton B: Cerebral circulatory and metabolic effects of perivascular neurotransmitters. CRC Crit Rev Clin Neurobiol 2: 357-419 (1987). (Pubitemid 17028741)
24. Matsubara J, Narumi J, Nagasue M, Sakamoto S, Yuasa K, Shimizu T: Postocclusive reactive hyperemia during vascular reconstruction. Internatl J Angiol 7: 222-227 (1998). (Pubitemid 28268531)
25. 2+ influx via P2X purinoceptors in the coronary arterioles of golden hamsters. Arch Histol Cytol 67: 95-105 (2004).
26. Miranda FJ, Torregrosa G, Salom JB, Alabadi JA, Jover T, Barbera MD, Alborch E: Characterization of 5-hydroxytryptamine receptors in goat cerebral arteries. Gen Pharmacol 26: 1267-1272 (1995).
27. Misaki T, Satoh Y, Saino T, Ogawa A: The role of protease-activated receptors on the intracellular calcium ion dynamics of vascular smooth muscles, with special reference to cerebral arterioles. Arch Histol Cytol 69: 49-60 (2006).
28. Ozawa E, Hosoi K, Ebashi S: Reversible stimulation of muscle phosphorylase b kinase by low concentrations of calcium ions. J Biochem (Tokyo) 61: 531-533 (1967).
29. Racke K, Reimann A, Schworer H, Kilbinger H: Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 73: 83-87 (1996). (Pubitemid 26008766)
30. Ramage AG, Villalón CM: 5-Hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 29: 472-481 (2008).
31. Rapport MM: Serum vasoconstrictor (serotonin). V: The presence of creatinine in the complex. A proposed structure of the vasoconstrictor principle. J Biol Chem 186: 615-623 (1949).
32. Roth BL, Willins DL, Kristiansen K, Kroeze WK: 5-Hydroxytryptamine2- family receptors (5- hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther 79: 231-257 (1998). (Pubitemid 28393877)
33. Saida A, Ito H, Shibuya T, Watanabe Y: Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull 43: 69-80 (1997). (Pubitemid 27265795)
34. Saino T, Matsuura M, Satoh Y: Application of realtime confocal microscopy to intracellular calcium ion dynamics in rat arterioles. Histochem Cell Biol 117: 295-305 (2002a). (Pubitemid 34985035)
35. Saino T, Matsuura M, Satoh Y: Comparison of the effect of ATP on intracellular calcium ion dynamics between rat testicular and cerebral arteriole smooth muscle cells. Cell Calcium 32: 155-165 (2002b).
36. Saino T, Satoh Y: Application of real-time confocal laser scanning microscopy to observe living cells in tissue specimens. J Electron Microsc (Tokyo) 53: 49-56 (2004). (Pubitemid 38370856)
37. Sjaastad O: The significance of blood serotonin levels in migraine. A critical review. Acta Neurol Scand 51: 200-210 (1975).
38. Teng GQ, Williams J, Zhang L, Purdy R, Pearce WJ: Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries. Am J Physiol 275: R742-R753 (1998). (Pubitemid 28439819)
39. Ueki N, Sobue K, Kanda K, Hada T, Higashino K: Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Nat Acad Sci USA 84: 9049-9053 (1987).
40. Ullmer C, Schmuck K, Kalkman HO, Lübbert H: Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370: 215-221 (1995).
41. Van Nueten JM: Serotonin and the blood vessel wall. J Cardiovasc Pharmacol 7 (Suppl 7) : S49-S51 (1985).
42. Van Nueten JM, Janssens WJ, Vanhoutte PM: Serotonin and vascular reactivity. Pharmacol Res Commun 17: 585-608 (1985).
43. Vanhoutte PM, Cohen RA, Van Nueten JM: Serotonin and arterial vessels. J Cardiovasc Pharmacol 6 (Suppl 2): S421-S428 (1984).
44. 2+]i in rat afferent arteriole during constriction measured with confocal fluorescence microscopy. Am J Physiol 271: F1004-F1011 (1996).
45. Young AR, Hamel E, MacKenzie ET: Recent studies on the serotonergic innervation of the cerebral circulation: a review. In: Neural regulation of brain circulation, Vol.8 (Owman C, Hardebo JE ed) Elsevier, New York, 1986 (p.195-217). (Pubitemid 17215257)
46. Young AR, Hamel E, MacKenzie ET, Seylaz J, Verrecchia C: The multiple actions of 5-hydroxytryptamine on cerebrovascular smooth muscle. In: Neural messengers in vascular function, Vol.10 (Nobin A, Owman C, Arnello-Nobin B, ed) Elsevier, New York, 1987 (p.57-74). (Pubitemid 18001067)
47. Zimmer R, Lang R, Oberdörster G: Post-ischemic reactive hyperemia of the isolated perfused brain of the dog. Pflüg Arch Eur J Physiol 328: 332-343 (1971).